Press Release: Shuwen : Shuwen Biotech Acquires Triple-Negative Breast Cancer Subtyping Technology

"Fudan Subtyping" to be Commercialized to Enable Personalized Therapies of TNBC and Improve Treatment Outcome DEQING, CHINA, March 7, 2023 /⁨EINPresswire.com⁩/ -- On March 3 TNBC Day, Shuwen Biotech, an integrated in vitro diagnostic company ...